Reduced vertical transmission rate and zidovudine - an update Newsletter Article 28 February 2013 Pages: 4 - 4
Demographic differences in therapy for HIV infection? Newsletter Article 28 February 2013 Pages: 5 - 5
QOL measures paramount in determining HIV treatment choice Newsletter Article 28 February 2013 Pages: 6 - 6
Antipsychotics - unlabelled indications widespread in children Newsletter Article 28 February 2013 Pages: 8 - 8
‘Single-shot’ extradural ropivacaine - effective sensory block Newsletter Article 28 February 2013 Pages: 8 - 8
Zileuton - a new first-line therapy for asthma? Sean Henahan Newsletter Article 28 February 2013 Pages: 9 - 9
Antineoplastic potential demonstrated in phase I trials Newsletter Article 28 February 2013 Pages: 11 - 11
High-dose sCD4 could be useful in cases of HIV exposure Newsletter Article 28 February 2013 Pages: 12 - 12
HRT effects in postmenopausal RA - further research warranted Newsletter Article 28 February 2013 Pages: 12 - 12
Only 20% of acute MI patients receive aspirin from their GP … Newsletter Article 28 February 2013 Pages: 13 - 13
On the way to curing HCV-associated cryoglobulinaemia Newsletter Article 28 February 2013 Pages: 13 - 13
Environmental factors may influence cancer patterns Newsletter Article 28 February 2013 Pages: 14 - 14
Continuous infusion regimen + BMT offers hope in Hodgkin’s disease Newsletter Article 28 February 2013 Pages: 14 - 14
Zidovudine delays disease progression in asymptomatic patients with HIV Newsletter Article 28 February 2013 Pages: 15 - 15
H. pylori infection through childhood bed-sharing? Newsletter Article 28 February 2013 Pages: 16 - 16
Simultaneous zidovudine/didanosine beneficial in symptomatic HIV Newsletter Article 28 February 2013 Pages: 16 - 16
Aspirin or warfarin for antithrombotic prophylaxis in atrial fibrillation? Newsletter Article 28 February 2013 Pages: 17 - 17
HIV vertical transmission risk predicted by anti-p24 titres Newsletter Article 28 February 2013 Pages: 19 - 19
What can we learn from PROFILE and FIRST? Rosie Stather Newsletter Article 28 February 2013 Pages: 20 - 22
Fluvastatin - revolutionising the cost of cholesterol-lowering Newsletter Article 28 February 2013 Pages: 22 - 22